Retension Pharmaceuticals, Inc. RTSN
11.35 USD -0.92 (-7.50%)
As ofNov 16, 2026, 11:23 AM EST
11.06 Day range 12.30
9.66 52-week range 18.64
- YTD
- +7.79%
- 1 year
- +7.79%
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 |
|---|---|---|
| -6.88M | -2.28M | |
| -6.30M | -1.91M | |
| -1.26 | -0.38 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 |
|---|---|---|
| 18.90M | 8.19M | |
| 21.45M | 8.37M | |
| 912.17K | 276.97K | |
| -7.78M | -1.73M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 |
|---|---|---|
| -7.78M | -1.76M | |
| 18.50M | 3.61M | |
| 10.72M | 1.86M |
